Holy Stone Healthcare Co (ROCO:4194) ROCE % : -70.03% (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Holy Stone Healthcare Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Holy Stone Healthcare Co's annualized ROCE % for the quarter that ended in Jun. 2024 was -70.03%.

Holy Stone Healthcare Co ROCE % Historical Data

The historical data trend for Holy Stone Healthcare Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holy Stone Healthcare Co ROCE % Chart

Holy Stone Healthcare Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-39.03

-23.39

-46.46

-35.43

-89.15

Holy Stone Healthcare Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial															-27.88	-28.69	-55.91	-119.81	-70.03

Holy Stone Healthcare Co ROCE % Calculation

Holy Stone Healthcare Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-283.723	/	( ( (614.66 - 74.259)	+	(200.591 - 104.515) )	/ 2 )
	=	-283.723	/	( (540.401	+	96.076)	/ 2 )
	=	-283.723	/	318.2385
	=	-89.15 %

Holy Stone Healthcare Co's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-173.836	/	( ( (200.591 - 104.515)	+	(432.54 - 32.179) )	/ 2 )
	=	-173.836	/	( ( 96.076	+	400.361 )	/ 2 )
	=	-173.836	/	248.2185
	=	-70.03 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Holy Stone Healthcare Co (ROCO:4194) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Holy Stone Healthcare Co ROCE % Related Terms

Thank you for viewing the detailed overview of Holy Stone Healthcare Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Holy Stone Healthcare Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Holy Stone Healthcare Co Ltd (ROCO:4194) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 88, Section 1, Neihu Road, 4th Floor, Neihu District, Taipei, TWN, 11493

Website

http://www.hshc.com.tw

Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.

Holy Stone Healthcare Co Headlines

No Headlines